He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce federal regulations on compounded we ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...

A RETROSPECTIVE study conducted by Mass General Brigham researchers has found that taking semaglutide before bariatric ...

Eli Lilly and Co. has begun selling its blockbuster weight-loss and diabetes drug Mounjaro in India, pipping rivals in a ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...

In an increasingly competitive telehealth weight loss market, thoughtful and transparent branding is critical.

By influencing multiple body systems simultaneously, tirzepatide offers a powerful approach to managing both diabetes and ...

looked at nine patients who reported vision loss after taking semaglutide or tirzepatide, the active ingredients in Ozempic, Wegovy, Mounjaro and Zepbound. Norris at his current weight of 230 ...

Ozempic (semaglutide) is an injectable medication initially designed to manage type 2 diabetes. Over the past few years, its potential to aid weight loss has captured more public attention.

Eli Lillys famous weight loss drug will now be sold in India after the drug maker received approval from CDSCO. What are its ...